Your browser doesn't support javascript.
loading
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball, Susan; Vickery, Jane; Hobart, Jeremy; Wright, Dave; Green, Colin; Shearer, James; Nunn, Andrew; Cano, Mayam Gomez; MacManus, David; Miller, David; Mallik, Shahrukh; Zajicek, John.
Afiliación
  • Ball S; Centre for Biostatistics, Bioinformatics and Biomarkers, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • Vickery J; Peninsula Clinical Trials Unit, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • Hobart J; Peninsula Clinical Trials Unit, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • Wright D; Centre for Biostatistics, Bioinformatics and Biomarkers, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • Green C; Health Economics Group, University of Exeter Medical School, Exeter, UK.
  • Shearer J; Health Economics Group, University of Exeter Medical School, Exeter, UK.
  • Nunn A; Medical Research Council Clinical Trials Unit, London, UK.
  • Cano MG; Centre for Biostatistics, Bioinformatics and Biomarkers, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
  • MacManus D; University College London's Institute of Neurology, London, UK.
  • Miller D; University College London's Institute of Neurology, London, UK.
  • Mallik S; University College London's Institute of Neurology, London, UK.
  • Zajicek J; Peninsula Clinical Trials Unit, Plymouth University Peninsula Schools of Medicine and Dentistry, Plymouth, UK.
Health Technol Assess ; 19(12): vii-viii, xxv-xxxi, 1-187, 2015 Feb.
Article en En | MEDLINE | ID: mdl-25676540
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dronabinol / Análisis Costo-Beneficio / Años de Vida Ajustados por Calidad de Vida / Esclerosis Múltiple Crónica Progresiva Tipo de estudio: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Health Technol Assess Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dronabinol / Análisis Costo-Beneficio / Años de Vida Ajustados por Calidad de Vida / Esclerosis Múltiple Crónica Progresiva Tipo de estudio: Clinical_trials / Health_economic_evaluation / Health_technology_assessment / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Health Technol Assess Asunto de la revista: PESQUISA EM SERVICOS DE SAUDE / TECNOLOGIA MEDICA Año: 2015 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido